GNOM
Global X Funds - Global X Genomics & Biotechnology ETF

450
Volume
9,658.00
52W High
$51.42
52W Low
$27.20
50D MA
$47.23
Prev Close
$46.83
Loading...
Loading...
News
all
press releases
News Placeholder
Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review
The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026.
Stocktwits·6d ago
<
...
1
>

Latest GNOM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.